CytoSorbents Corp (CTSO)
0.93
0.00 (0.00%)
USD |
NASDAQ |
May 07, 09:41
CytoSorbents Cash from Financing (Quarterly): 12.21M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.21M |
| September 30, 2023 | 0.6483M |
| June 30, 2023 | 0.9311M |
| March 31, 2023 | 0.6843M |
| December 31, 2022 | 5.00M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0404M |
| December 31, 2021 | -0.0809M |
| September 30, 2021 | 0.5897M |
| June 30, 2021 | 0.1299M |
| March 31, 2021 | 0.0766M |
| December 31, 2020 | -15.15M |
| September 30, 2020 | 56.38M |
| June 30, 2020 | 7.234M |
| March 31, 2020 | 17.88M |
| December 31, 2019 | 0.7728M |
| September 30, 2019 | 5.220M |
| June 30, 2019 | 0.1802M |
| March 31, 2019 | 2.005M |
| December 31, 2018 | 0.4755M |
| September 30, 2018 | 2.568M |
| June 30, 2018 | 7.979M |
| March 31, 2018 | 6.443M |
| December 31, 2017 | 2.908M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.689M |
| June 30, 2017 | 15.35M |
| March 31, 2017 | 0.1763M |
| December 31, 2016 | 0.053M |
| September 30, 2016 | 0.1012M |
| June 30, 2016 | 4.882M |
| March 31, 2016 | 0.0279M |
| December 31, 2015 | 0.5961M |
| September 30, 2015 | 0.5679M |
| June 30, 2015 | 0.4643M |
| March 31, 2015 | 10.01M |
| December 31, 2014 | 0.1746M |
| September 30, 2014 | 0.0297M |
| June 30, 2014 | 0.0093M |
| March 31, 2014 | 9.803M |
| December 31, 2013 | 1.18M |
| September 30, 2013 | 1.010M |
| June 30, 2013 | 1.563M |
| March 31, 2013 | 0.45M |
| December 31, 2012 | 0.4606M |
| September 30, 2012 | 0.95M |
| June 30, 2012 | 1.10M |
| March 31, 2012 | 1.70M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.0022M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-15.15M
Minimum
Dec 2020
56.38M
Maximum
Sep 2020
4.877M
Average
0.6483M
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
| Delcath Systems Inc | 0.001M |
| Star Equity Holdings Inc | 0.987M |
| Exact Sciences Corp | 10.04M |
| Illumina Inc | 35.00M |
| Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.407M |
| Cash from Investing (Quarterly) | -0.1359M |
| Free Cash Flow | -22.59M |
| Free Cash Flow Per Share (Quarterly) | -0.1406 |
| Free Cash Flow to Equity (Quarterly) | -6.554M |
| Free Cash Flow to Firm (Quarterly) | -6.498M |
| Free Cash Flow Yield | -54.40% |